Advancement for people with Parkinson's in light therapy trial
Australian-founded medical technology company SYMBYX today announced compelling results from a 72-week randomized controlled trial (RCT) demonstrating improvements in a range of Parkinson's disease symptoms. These results, ...
Oct 23, 2025
0
0









